Todos os posts

Vacinas aplicadas nos últimos 20 anos podem evitar 50 milhões de mortes em países de baixa e média rendas.

12 Ago, 2021 | 12:00h

Vaccines given in last 20 years could prevent 50 million deaths in LMICs – Imperial College London

Estudo original: Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world – eLife

Eventos adversos e condições adquiridas em hospital associadas com cuidados de baixo valor nos beneficiários do Medicare.

12 Ago, 2021 | 11:59h

Adverse Events and Hospital-Acquired Conditions Associated With Potential Low-Value Care in Medicare Beneficiaries – JAMA Health Forum

Comentário: Hospital overuse linked to thousands of adverse events each year – Lown Institute

Comentário no Twitter (fio – clique para saber mais)

Research by @kelsey_chalmers @AElshaug @DrVikasSaini @ShannonBrownlee shows that spinal fusion overuse is associated with >1000 more adverse events for Medicare beneficiaries each year.https://t.co/L83CDNqFiC

— Lown Institute (@lowninstitute) July 27, 2021

Breve revisão | Unhas nas doenças sistêmicas.

12 Ago, 2021 | 11:57h

Nails in systemic disease – Clinical Medicine Journal

Psoríase: uma breve visão geral.

12 Ago, 2021 | 11:56h

Psoriasis: a brief overview – Clinical Medicine Journal

Breve revisão | Doenças bolhosas imunes.

12 Ago, 2021 | 11:54h

Immunobullous disease – Clinical Medicine Journal

Manifestações cutâneas das infecções: atualização para clínicos gerais.

12 Ago, 2021 | 11:53h

Cutaneous manifestations of infections: an update for general physicians – Clinical Medicine Journal

Breve revisão | Avanços na dermatite atópica.

12 Ago, 2021 | 11:52h

Advances in atopic dermatitis – Clinical Medicine Journal

Estudo randomizado PRINCIPLE | Budesonida inalatória melhora o tempo de recuperação da COVID-19 em pessoas com alto risco de complicações na comunidade.

11 Ago, 2021 | 11:02h

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet

Comentário convidado: The use of inhaled corticosteroids in early-stage COVID-19

Diretriz OMS para vigilância das variantes do SARS-CoV-2.

11 Ago, 2021 | 11:00h

Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021 – World Health Organization

Comentário no Twitter (fio – clique para saber mais)

🆕 WHO guidance for national surveillance of #COVID19 virus variants 👉https://t.co/YHRsazZhPA

Standardizing the monitoring & reporting of the variants will give us a better understanding of the virus at a global scale. pic.twitter.com/VNcxv8gyaa

— World Health Organization (WHO) (@WHO) August 10, 2021

M-A | Infecção assintomática por SARS-CoV-2 – “Estima-se que a porcentagem de infecções que não levaram a sintomas clínicos, portanto, de fato assintomáticas, foi em torno de 35,1%.”

11 Ago, 2021 | 10:58h

Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis – Proceedings of the National Academy of Sciences

Comentário no Twitter

The best comprehensive review of the asymptomatic status with Covid, >350 studies, just out @PNASNews https://t.co/xyfgyGXANL
Overall: true, never had symptoms 35%; children 47%@Pratha_Sah @Alison_Galvani @MeaganCFitz @YaleSPH & colleagues
(wonder what the rate is w/ Delta) pic.twitter.com/9W6wbvQno6

— Eric Topol (@EricTopol) August 10, 2021